Dr. Page is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 W Magnolia Ave
Fort Worth, TX 76104Phone+1 817-759-7000- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
- Osteopathic Medical Center of TexasResidency, Internal Medicine, 1991 - 1994
- University of North TexasPhD, Biology (Pharmacology), 1986 - 1991
- Texas College of Osteopathic MedicineClass of 1991
- Baylor College of DentistryMS, Physiology, 1984 - 1986
- Baylor University Graduate School , Baylor College of DentistryMSc, Physiology, 1984 - 1986
- Southwestern UniversityB.S., Chemistry and Biology, 1980 - 1984
Certifications & Licensure
- TX State License 1992 - 2025
- AOA Board of Internal Medicine Oncology
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
- Distinguished Alumnus Grand Prairie High School, 2010
- Outstanding Preceptor of the Year Physician Assistant Program, UNTHSC, 2007
- Join now to see all
Clinical Trials
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16
- Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Start of enrollment: 2013 Mar 14
- Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Feb 05
- Join now to see all
Publications & Presentations
PubMed
- Achieving white blood cell equity: are the safety profiles of biosimilar and reference pegfilgrastims comparable?Arturo Loaiza-Bonilla, Ray D Page> ;Future Oncology. 2024 Jan 1
- Soft Tissue Mass Extramedullary Plasmacytoma Following Radiation Therapy for Solitary Bone Plasmacytoma.Jong H Kim, Ray D Page, Yen-Chung Wang, Minh-Triet Nguyen, Kunal Elete> ;Cureus. 2023 Aug 1
- Exceedingly Rare Bilateral Synchronous Germ Cell Testicular Tumors With Different Histopathological Features.Jong H Kim, Ray D Page, Gregory A Moses, Rod C Columbres> ;Cureus. 2023 Jul 1
- Join now to see all
Journal Articles
- Breast Cancer International Research Group. Adjuvant trastuzumab in HER2-positive breast cancer.Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F..., N Engl J Med, 10/1/2011
- A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell...Blumenschein GR Jr, Kabbinavar F, Menon H, Mok TS, Stephenson J, Beck JT, Lakshmaiah K, Reckamp K, Hei YJ, Kracht K, Sun YN, Sikorski R, Schwartzberg L; Motesanib NSCL..., Ann Oncol, 9/1/2011
- Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.Coiffier B, Osmanov EA, Hong X, et. al, Lancet Oncol, 8/1/2011
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Medicare 2005 Demonstration Project: Patient reporting of nausea symptoms and its impact on improving quality of patient care.Mueller, B. and Page, R.D., ASCO Proceedings, 1/1/2007
- Prospective multi-center phase II trial of dose dense docetaxel and vinorelbine with filgrastim support in subjects with advanced non-small-cell lung cancer (NSCLC).Page, R.D., Smith, G.F., Beall, C.L., Ross, M.B., et. al., ASCO Proceedings, 1/1/2004
- A multicenter web-based Phase III study to test the survival equivalence of a non-platinum based versus a platinum-based therapy for advanced non-small cell lung cance...Rigas, J., Carey, M., Cole, B., Evans, A., Page, R.D., et. al., ASCO Proceedings, 1/1/2004
- Join now to see all
Lectures
- "Experience with Via OncologyTreatment Pathways in Community Practice"Fox-Chase Cancer Center, Philadelphia, PA - 12/1/2011
- "Prostate Cancer Update"Fort Worth, Tx - 11/1/2011
- "Cancer Prevention and Early Detection"Fort Worth, Tx - 11/1/2011
- Join now to see all
Other
- New Guidelines for the Screening of Cervical Cancer.McClennen, R., Wiggins, J., Page, R.D., Texas D.O.
10/1/2003 - Medical Oncology Fellows Home Page (Worl Wide Web/Internet)Page, R.D.
http://mda.uth.tmc.edu
1/1/1996 - Hyperthyroidism: Physical Examination findings. (Audio Visual Presentation)Page, R.D., TCOM LC Files
1/1/1993 - Join now to see all
Press Mentions
- In Growth Spurt Since Joining OneOncology, the Center for Cancer and Blood Disorders in Fort Worth Adds 3 Practices and 14 PhysiciansJuly 12th, 2021
- Artificial Intelligence in Oncology Care Saved $3 Million for One Texas ProviderNovember 19th, 2020
- Hurry up and Wait: Docs Say Insurers Increasingly InterfereJuly 29th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Baylor Scott & White All Saints Medical Center - Fort WorthFort Worth, Texas
- Texas Health Harris Methodist Hospital Fort WorthFort Worth, Texas
- Texas Health Huguley Hospital Fort Worth SouthBurleson, Texas
- Medical City WeatherfordWeatherford, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: